調査レポート | • レポートコード：GIR-2104Z06333 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、消化器がん治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。消化器がん治療の種類別市場規模（手術、標的薬物療法、化学療法、アジュバント化学療法、放射線療法）、用途別市場規模（病院、診療所、研究センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・消化器がん治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、F. Hoffmann、GlaxoSmithKline、Merck、Novartis AG、Otsuka Holdings、Stryker Corporation、Boston Scientific Corporation、Johnson and Johnson、CONMED Corporation、Bristol-Myers Squibb、Pfizer、Celltrion Inc、Amgen Limited、Celgene Corporation、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：手術、標的薬物療法、化学療法、アジュバント化学療法、放射線療法 ・用途別分析2016年-2026年：病院、診療所、研究センター、その他 ・消化器がん治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・消化器がん治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・消化器がん治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・消化器がん治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・消化器がん治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gastrointestinal Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gastrointestinal Cancer Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Gastrointestinal Cancer Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gastrointestinal Cancer Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy
Market segment by Application, can be divided into
Hospitals
Clinics
Research Centers
Others
Market segment by players, this report covers
Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Gastrointestinal Cancer Treatment
1.2 Classification of Gastrointestinal Cancer Treatment by Type
1.2.1 Overview: Global Gastrointestinal Cancer Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Type in 2020
1.2.3 Surgery
1.2.4 Targeted Drugs Therapy
1.2.5 Chemo Therapy
1.2.6 Adjuvant Chemotherapy
1.2.7 Radiation Therapy
1.3 Global Gastrointestinal Cancer Treatment Market by Application
1.3.1 Overview: Global Gastrointestinal Cancer Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Global Gastrointestinal Cancer Treatment Market Size & Forecast
1.5 Global Gastrointestinal Cancer Treatment Market Size and Forecast by Region
1.5.1 Global Gastrointestinal Cancer Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gastrointestinal Cancer Treatment Market Size by Region, (2016-2021)
1.5.3 North America Gastrointestinal Cancer Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Gastrointestinal Cancer Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gastrointestinal Cancer Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Gastrointestinal Cancer Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gastrointestinal Cancer Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastrointestinal Cancer Treatment Market Drivers
1.6.2 Gastrointestinal Cancer Treatment Market Restraints
1.6.3 Gastrointestinal Cancer Treatment Trends Analysis
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Gastrointestinal Cancer Treatment Product and Solutions
2.1.4 Eli Lilly Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 F. Hoffmann
2.2.1 F. Hoffmann Details
2.2.2 F. Hoffmann Major Business
2.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Product and Solutions
2.2.4 F. Hoffmann Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 F. Hoffmann Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Product and Solutions
2.3.4 GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Gastrointestinal Cancer Treatment Product and Solutions
2.4.4 Merck Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Recent Developments and Future Plans
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Gastrointestinal Cancer Treatment Product and Solutions
2.5.4 Novartis AG Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novartis AG Recent Developments and Future Plans
2.6 Otsuka Holdings
2.6.1 Otsuka Holdings Details
2.6.2 Otsuka Holdings Major Business
2.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Product and Solutions
2.6.4 Otsuka Holdings Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Otsuka Holdings Recent Developments and Future Plans
2.7 Stryker Corporation
2.7.1 Stryker Corporation Details
2.7.2 Stryker Corporation Major Business
2.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Product and Solutions
2.7.4 Stryker Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Stryker Corporation Recent Developments and Future Plans
2.8 Boston Scientific Corporation
2.8.1 Boston Scientific Corporation Details
2.8.2 Boston Scientific Corporation Major Business
2.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Product and Solutions
2.8.4 Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Boston Scientific Corporation Recent Developments and Future Plans
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business
2.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Product and Solutions
2.9.4 Johnson and Johnson Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Johnson and Johnson Recent Developments and Future Plans
2.10 CONMED Corporation
2.10.1 CONMED Corporation Details
2.10.2 CONMED Corporation Major Business
2.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Product and Solutions
2.10.4 CONMED Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 CONMED Corporation Recent Developments and Future Plans
2.11 Bristol-Myers Squibb
2.11.1 Bristol-Myers Squibb Details
2.11.2 Bristol-Myers Squibb Major Business
2.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product and Solutions
2.11.4 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Gastrointestinal Cancer Treatment Product and Solutions
2.12.4 Pfizer Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Pfizer Recent Developments and Future Plans
2.13 Celltrion Inc
2.13.1 Celltrion Inc Details
2.13.2 Celltrion Inc Major Business
2.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Product and Solutions
2.13.4 Celltrion Inc Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Celltrion Inc Recent Developments and Future Plans
2.14 Amgen Limited
2.14.1 Amgen Limited Details
2.14.2 Amgen Limited Major Business
2.14.3 Amgen Limited Gastrointestinal Cancer Treatment Product and Solutions
2.14.4 Amgen Limited Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Amgen Limited Recent Developments and Future Plans
2.15 Celgene Corporation
2.15.1 Celgene Corporation Details
2.15.2 Celgene Corporation Major Business
2.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Product and Solutions
2.15.4 Celgene Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Celgene Corporation Recent Developments and Future Plans
2.16 Sanofi
2.16.1 Sanofi Details
2.16.2 Sanofi Major Business
2.16.3 Sanofi Gastrointestinal Cancer Treatment Product and Solutions
2.16.4 Sanofi Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gastrointestinal Cancer Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Gastrointestinal Cancer Treatment Players Market Share
3.2.2 Top 10 Gastrointestinal Cancer Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Gastrointestinal Cancer Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gastrointestinal Cancer Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Gastrointestinal Cancer Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2016-2021)
5.2 Gastrointestinal Cancer Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gastrointestinal Cancer Treatment Revenue by Type (2016-2026)
6.2 North America Gastrointestinal Cancer Treatment Revenue by Application (2016-2026)
6.3 North America Gastrointestinal Cancer Treatment Market Size by Country
6.3.1 North America Gastrointestinal Cancer Treatment Revenue by Country (2016-2026)
6.3.2 United States Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gastrointestinal Cancer Treatment Revenue by Type (2016-2026)
7.2 Europe Gastrointestinal Cancer Treatment Revenue by Application (2016-2026)
7.3 Europe Gastrointestinal Cancer Treatment Market Size by Country
7.3.1 Europe Gastrointestinal Cancer Treatment Revenue by Country (2016-2026)
7.3.2 Germany Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
7.3.3 France Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region
8.3.1 Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Region (2016-2026)
8.3.2 China Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.5 India Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gastrointestinal Cancer Treatment Revenue by Type (2016-2026)
9.2 South America Gastrointestinal Cancer Treatment Revenue by Application (2016-2026)
9.3 South America Gastrointestinal Cancer Treatment Market Size by Country
9.3.1 South America Gastrointestinal Cancer Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country
10.3.1 Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Gastrointestinal Cancer Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Gastrointestinal Cancer Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gastrointestinal Cancer Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gastrointestinal Cancer Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gastrointestinal Cancer Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gastrointestinal Cancer Treatment Revenue Market Share by Region (2021-2026)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Gastrointestinal Cancer Treatment Product and Solutions
Table 9. Eli Lilly Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. F. Hoffmann Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann Major Business
Table 12. F. Hoffmann Gastrointestinal Cancer Treatment Product and Solutions
Table 13. F. Hoffmann Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Gastrointestinal Cancer Treatment Product and Solutions
Table 17. GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Gastrointestinal Cancer Treatment Product and Solutions
Table 21. Merck Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 23. Novartis AG Major Business
Table 24. Novartis AG Gastrointestinal Cancer Treatment Product and Solutions
Table 25. Novartis AG Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Otsuka Holdings Corporate Information, Head Office, and Major Competitors
Table 27. Otsuka Holdings Major Business
Table 28. Otsuka Holdings Gastrointestinal Cancer Treatment Product and Solutions
Table 29. Otsuka Holdings Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Stryker Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Stryker Corporation Major Business
Table 32. Stryker Corporation Gastrointestinal Cancer Treatment Product and Solutions
Table 33. Stryker Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Boston Scientific Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Boston Scientific Corporation Major Business
Table 36. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product and Solutions
Table 37. Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 39. Johnson and Johnson Major Business
Table 40. Johnson and Johnson Gastrointestinal Cancer Treatment Product and Solutions
Table 41. Johnson and Johnson Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. CONMED Corporation Corporate Information, Head Office, and Major Competitors
Table 43. CONMED Corporation Major Business
Table 44. CONMED Corporation Gastrointestinal Cancer Treatment Product and Solutions
Table 45. CONMED Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 47. Bristol-Myers Squibb Major Business
Table 48. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product and Solutions
Table 49. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Pfizer Corporate Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Gastrointestinal Cancer Treatment Product and Solutions
Table 53. Pfizer Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Celltrion Inc Corporate Information, Head Office, and Major Competitors
Table 55. Celltrion Inc Major Business
Table 56. Celltrion Inc Gastrointestinal Cancer Treatment Product and Solutions
Table 57. Celltrion Inc Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Amgen Limited Corporate Information, Head Office, and Major Competitors
Table 59. Amgen Limited Major Business
Table 60. Amgen Limited Gastrointestinal Cancer Treatment Product and Solutions
Table 61. Amgen Limited Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 63. Celgene Corporation Major Business
Table 64. Celgene Corporation Gastrointestinal Cancer Treatment Product and Solutions
Table 65. Celgene Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Sanofi Corporate Information, Head Office, and Major Competitors
Table 67. Sanofi Major Business
Table 68. Sanofi Gastrointestinal Cancer Treatment Product and Solutions
Table 69. Sanofi Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Gastrointestinal Cancer Treatment Revenue (USD Million) by Players (2019-2021)
Table 71. Global Gastrointestinal Cancer Treatment Revenue Share by Players (2019-2021)
Table 72. Breakdown of Gastrointestinal Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Gastrointestinal Cancer Treatment Players Head Office, Products and Services Provided
Table 74. Gastrointestinal Cancer Treatment Mergers & Acquisitions in the Past Five Years
Table 75. Gastrointestinal Cancer Treatment New Entrants and Expansion Plans
Table 76. Global Gastrointestinal Cancer Treatment Revenue (USD Million) by Type (2016-2021)
Table 77. Global Gastrointestinal Cancer Treatment Revenue Share by Type (2016-2021)
Table 78. Global Gastrointestinal Cancer Treatment Revenue Forecast by Type (2021-2026)
Table 79. Global Gastrointestinal Cancer Treatment Revenue by Application (2016-2021)
Table 80. Global Gastrointestinal Cancer Treatment Revenue Forecast by Application (2021-2026)
Table 81. North America Gastrointestinal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Gastrointestinal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Gastrointestinal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Gastrointestinal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Gastrointestinal Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Gastrointestinal Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Gastrointestinal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Gastrointestinal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Gastrointestinal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Gastrointestinal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Gastrointestinal Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Gastrointestinal Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Gastrointestinal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Gastrointestinal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Gastrointestinal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Gastrointestinal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Gastrointestinal Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Gastrointestinal Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Gastrointestinal Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gastrointestinal Cancer Treatment Picture
Figure 2. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type in 2020
Figure 3. Surgery
Figure 4. Targeted Drugs Therapy
Figure 5. Chemo Therapy
Figure 6. Adjuvant Chemotherapy
Figure 7. Radiation Therapy
Figure 8. Gastrointestinal Cancer Treatment Revenue Market Share by Application in 2020
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Research Centers Picture
Figure 12. Others Picture
Figure 13. Global Gastrointestinal Cancer Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Gastrointestinal Cancer Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Gastrointestinal Cancer Treatment Revenue Market Share by Region (2016-2026)
Figure 16. Global Gastrointestinal Cancer Treatment Revenue Market Share by Region in 2020
Figure 17. North America Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Gastrointestinal Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Gastrointestinal Cancer Treatment Market Drivers
Figure 22. Gastrointestinal Cancer Treatment Market Restraints
Figure 23. Gastrointestinal Cancer Treatment Market Trends
Figure 24. Eli Lilly Recent Developments and Future Plans
Figure 25. F. Hoffmann Recent Developments and Future Plans
Figure 26. GlaxoSmithKline Recent Developments and Future Plans
Figure 27. Merck Recent Developments and Future Plans
Figure 28. Novartis AG Recent Developments and Future Plans
Figure 29. Otsuka Holdings Recent Developments and Future Plans
Figure 30. Stryker Corporation Recent Developments and Future Plans
Figure 31. Boston Scientific Corporation Recent Developments and Future Plans
Figure 32. Johnson and Johnson Recent Developments and Future Plans
Figure 33. CONMED Corporation Recent Developments and Future Plans
Figure 34. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 35. Pfizer Recent Developments and Future Plans
Figure 36. Celltrion Inc Recent Developments and Future Plans
Figure 37. Amgen Limited Recent Developments and Future Plans
Figure 38. Celgene Corporation Recent Developments and Future Plans
Figure 39. Sanofi Recent Developments and Future Plans
Figure 41. Global Gastrointestinal Cancer Treatment Revenue Share by Players in 2020
Figure 42. Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Gastrointestinal Cancer Treatment Revenue Market Share in 2020
Figure 44. Global Top 10 Players Gastrointestinal Cancer Treatment Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Gastrointestinal Cancer Treatment Revenue Share by Type in 2020
Figure 47. Global Gastrointestinal Cancer Treatment Market Share Forecast by Type (2021-2026)
Figure 48. Global Gastrointestinal Cancer Treatment Revenue Share by Application in 2020
Figure 49. Global Gastrointestinal Cancer Treatment Market Share Forecast by Application (2021-2026)
Figure 50. North America Gastrointestinal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 51. North America Gastrointestinal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 52. North America Gastrointestinal Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 53. United States Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Gastrointestinal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 57. Europe Gastrointestinal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 58. Europe Gastrointestinal Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 59. Germany Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Gastrointestinal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Gastrointestinal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Gastrointestinal Cancer Treatment Revenue Market Share by Region (2016-2026)
Figure 67. China Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Gastrointestinal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 74. South America Gastrointestinal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 75. South America Gastrointestinal Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Gastrointestinal Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Gastrointestinal Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Gastrointestinal Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Gastrointestinal Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
世界の消化器がんデバイス市場 2021：企業別、地域別、種類・用途別 The Gastrointestinal Cancer Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 世界の消化器がん治療薬市場 2021：企業別、地域別、種類・用途別 The Gastrointestinal Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の消化管間質腫瘍（GIST）治療市場規模・現状・予測（2021年-2027年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
- 世界の陰茎がん治療市場規模・現状・予測（2021年-2027年） Therapy of penile cancer. Market Analysis and Insights: Global Penile Cancer Treatment Market The global Penile Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
- 世界の転移性がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…